117 related articles for article (PubMed ID: 12494449)
1. Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression.
Mauro L; Salerno M; Morelli C; Boterberg T; Bracke ME; Surmacz E
J Cell Physiol; 2003 Feb; 194(2):108-16. PubMed ID: 12494449
[TBL] [Abstract][Full Text] [Related]
2. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
3. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR
Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650
[TBL] [Abstract][Full Text] [Related]
4. Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model.
Krueckl SL; Sikes RA; Edlund NM; Bell RH; Hurtado-Coll A; Fazli L; Gleave ME; Cox ME
Cancer Res; 2004 Dec; 64(23):8620-9. PubMed ID: 15574769
[TBL] [Abstract][Full Text] [Related]
5. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
6. IGF-IR: potential role in antitumor agents.
Guerreiro AS; Boller D; Doepfner KT; Arcaro A
Drug News Perspect; 2006 Jun; 19(5):261-72. PubMed ID: 16941048
[TBL] [Abstract][Full Text] [Related]
7. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D
Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I receptor signaling blockade combined with radiation.
Allen GW; Saba C; Armstrong EA; Huang SM; Benavente S; Ludwig DL; Hicklin DJ; Harari PM
Cancer Res; 2007 Feb; 67(3):1155-62. PubMed ID: 17283150
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.
Sarfstein R; Maor S; Reizner N; Abramovitch S; Werner H
Mol Cell Endocrinol; 2006 Jun; 252(1-2):241-6. PubMed ID: 16647191
[TBL] [Abstract][Full Text] [Related]
14. IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness.
Hsu YM; Chou CY; Chen HH; Lee WY; Chen YF; Lin PW; Alper SL; Ellory JC; Shen MR
J Cell Physiol; 2007 Mar; 210(3):626-36. PubMed ID: 17133354
[TBL] [Abstract][Full Text] [Related]
15. IGF-I receptor, cell-cell adhesion, tumour development and progression.
Mauro L; Surmacz E
J Mol Histol; 2004 Mar; 35(3):247-53. PubMed ID: 15339044
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
17. Regulation of IGF-I receptor signaling in tumor cells.
O'Connor R
Horm Metab Res; 2003; 35(11-12):771-7. PubMed ID: 14710357
[TBL] [Abstract][Full Text] [Related]
18. Reversibility and recurrence of IGF-IR-induced mammary tumors.
Jones RA; Campbell CI; Wood GA; Petrik JJ; Moorehead RA
Oncogene; 2009 May; 28(21):2152-62. PubMed ID: 19377512
[TBL] [Abstract][Full Text] [Related]
19. Rapid induction of IGF-IR signaling in normal and tumor tissue following intravenous injection of IGF-I in mice.
Lee AV; Taylor ST; Greenall J; Mills JD; Tonge DW; Zhang P; George J; Fiorotto ML; Hadsell DL
Horm Metab Res; 2003; 35(11-12):651-5. PubMed ID: 14710342
[TBL] [Abstract][Full Text] [Related]
20. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]